Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17308244rdf:typepubmed:Citationlld:pubmed
pubmed-article:17308244lifeskim:mentionsumls-concept:C0008059lld:lifeskim
pubmed-article:17308244lifeskim:mentionsumls-concept:C0036043lld:lifeskim
pubmed-article:17308244lifeskim:mentionsumls-concept:C0887947lld:lifeskim
pubmed-article:17308244lifeskim:mentionsumls-concept:C0040808lld:lifeskim
pubmed-article:17308244pubmed:issue3lld:pubmed
pubmed-article:17308244pubmed:dateCreated2007-3-2lld:pubmed
pubmed-article:17308244pubmed:abstractTextTo improve adherence and virologic suppression, we assessed the feasibility and effectiveness of a once-daily regimen of efavirenz with 3 nucleoside reverse transcriptase inhibitors as first-line or second-line highly active antiretroviral therapy in a cohort of HIV-1-infected children.lld:pubmed
pubmed-article:17308244pubmed:languageenglld:pubmed
pubmed-article:17308244pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17308244pubmed:citationSubsetAIMlld:pubmed
pubmed-article:17308244pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17308244pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17308244pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17308244pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17308244pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17308244pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17308244pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17308244pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17308244pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17308244pubmed:statusMEDLINElld:pubmed
pubmed-article:17308244pubmed:monthMarlld:pubmed
pubmed-article:17308244pubmed:issn1098-4275lld:pubmed
pubmed-article:17308244pubmed:authorpubmed-author:KuijpersTaco...lld:pubmed
pubmed-article:17308244pubmed:authorpubmed-author:ScherpbierHen...lld:pubmed
pubmed-article:17308244pubmed:authorpubmed-author:JurriaansSuza...lld:pubmed
pubmed-article:17308244pubmed:authorpubmed-author:LangeJoep M...lld:pubmed
pubmed-article:17308244pubmed:authorpubmed-author:BekkerVincent...lld:pubmed
pubmed-article:17308244pubmed:authorpubmed-author:PajkrtDasjaDlld:pubmed
pubmed-article:17308244pubmed:issnTypeElectroniclld:pubmed
pubmed-article:17308244pubmed:volume119lld:pubmed
pubmed-article:17308244pubmed:ownerNLMlld:pubmed
pubmed-article:17308244pubmed:authorsCompleteYlld:pubmed
pubmed-article:17308244pubmed:paginatione705-15lld:pubmed
pubmed-article:17308244pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:17308244pubmed:meshHeadingpubmed-meshheading:17308244...lld:pubmed
pubmed-article:17308244pubmed:meshHeadingpubmed-meshheading:17308244...lld:pubmed
pubmed-article:17308244pubmed:meshHeadingpubmed-meshheading:17308244...lld:pubmed
pubmed-article:17308244pubmed:meshHeadingpubmed-meshheading:17308244...lld:pubmed
pubmed-article:17308244pubmed:meshHeadingpubmed-meshheading:17308244...lld:pubmed
pubmed-article:17308244pubmed:meshHeadingpubmed-meshheading:17308244...lld:pubmed
pubmed-article:17308244pubmed:meshHeadingpubmed-meshheading:17308244...lld:pubmed
pubmed-article:17308244pubmed:meshHeadingpubmed-meshheading:17308244...lld:pubmed
pubmed-article:17308244pubmed:meshHeadingpubmed-meshheading:17308244...lld:pubmed
pubmed-article:17308244pubmed:meshHeadingpubmed-meshheading:17308244...lld:pubmed
pubmed-article:17308244pubmed:meshHeadingpubmed-meshheading:17308244...lld:pubmed
pubmed-article:17308244pubmed:meshHeadingpubmed-meshheading:17308244...lld:pubmed
pubmed-article:17308244pubmed:meshHeadingpubmed-meshheading:17308244...lld:pubmed
pubmed-article:17308244pubmed:meshHeadingpubmed-meshheading:17308244...lld:pubmed
pubmed-article:17308244pubmed:meshHeadingpubmed-meshheading:17308244...lld:pubmed
pubmed-article:17308244pubmed:meshHeadingpubmed-meshheading:17308244...lld:pubmed
pubmed-article:17308244pubmed:meshHeadingpubmed-meshheading:17308244...lld:pubmed
pubmed-article:17308244pubmed:meshHeadingpubmed-meshheading:17308244...lld:pubmed
pubmed-article:17308244pubmed:meshHeadingpubmed-meshheading:17308244...lld:pubmed
pubmed-article:17308244pubmed:meshHeadingpubmed-meshheading:17308244...lld:pubmed
pubmed-article:17308244pubmed:meshHeadingpubmed-meshheading:17308244...lld:pubmed
pubmed-article:17308244pubmed:meshHeadingpubmed-meshheading:17308244...lld:pubmed
pubmed-article:17308244pubmed:meshHeadingpubmed-meshheading:17308244...lld:pubmed
pubmed-article:17308244pubmed:meshHeadingpubmed-meshheading:17308244...lld:pubmed
pubmed-article:17308244pubmed:meshHeadingpubmed-meshheading:17308244...lld:pubmed
pubmed-article:17308244pubmed:meshHeadingpubmed-meshheading:17308244...lld:pubmed
pubmed-article:17308244pubmed:year2007lld:pubmed
pubmed-article:17308244pubmed:articleTitleOnce-daily highly active antiretroviral therapy for HIV-infected children: safety and efficacy of an efavirenz-containing regimen.lld:pubmed
pubmed-article:17308244pubmed:affiliationEmma Children's Hospital, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.lld:pubmed
pubmed-article:17308244pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17308244pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17308244lld:pubmed